Composition: Each 1 ml contains:
Enrofloxacin 100 mg
Bromhexine hydrochloride 10 mg
The new drug MUCOTRYL combines the effect of two potent ingredients; bromhexine will decrease the viscosity of tenacious mucus secretions, this liquefaction of mucoid respiratory secretions will aid ciliary action and expectoration process, reduce dyspnea symptoms and increase the functional compartment of the lung. Bromhexine is been demonstrated to enhance the concentration of the antibacterial Enrofloxacin at the target site thus resulting in more rapid recovery.
Enrofloxacin produces a comprehensive and extensive control against a wide range of infectious diseases of respiratory, digestive, dermatological and urogenital systems. Enrofloxacin activity covers the wide Gram-positive and Gram-negative spectrum including those incriminated in different pathological conditions of dogs like tonsillitis, pneumonia and respiratory infections, cystitis and rhinitis, these bacteria include Escherichia coli, Proteus mirabilis, Staphylococcus aureus, Staphylococcus intermedius and Klebsiella pneumoniae, to which Enrofloxacin had shown marked clinical efficacy.
MUCOTRYL is indicated in poultry in treatment of conditions of respiratory tract associated with retention of mucoid secretion such as; bronchitis, bacterial pneumonia and associated respiratory infections termed CRD (Chronic Respiratory Disease) caused by Mycoplasma gallispeticum, also indicated for treatment of salmonellosis, colibacillosis, also in digestive and urogenital systems. Its activity covers the whole Gram-positive and Gram-negative bacteria including: E. coli, Salmonella, Staphylococcus, Haemophilus, Pasteurella, Streptococcus, and many diseases caused by Mycoplasma and Chlamydia.
Dosage and Administration:
Poultry: 1 ml per 2 liters of drinking water daily for 3-5 days.
(To obtain a concentration of 50 ppm of enrofloxacin).
Poultry: 5 days.
Store in a dark place at a temperature below 30 ºC.
100, 500 ml and 1 liter plastic bottles.
FOR VETERINARY USE ONLY